Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Treatment of depression in the elderly: effect of physical illness on response.

Evans M, Hammond M, Wilson K, Lye M, Copeland J.

Int J Geriatr Psychiatry. 1997 Dec;12(12):1189-94.

PMID:
9444543
2.

Placebo-controlled treatment trial of depression in elderly physically ill patients.

Evans M, Hammond M, Wilson K, Lye M, Copeland J.

Int J Geriatr Psychiatry. 1997 Aug;12(8):817-24.

PMID:
9283926
3.

Impact of physical illness on quality of life and antidepressant response in geriatric major depression. Fluoxetine Collaborative Study Group.

Small GW, Birkett M, Meyers BS, Koran LM, Bystritsky A, Nemeroff CB.

J Am Geriatr Soc. 1996 Oct;44(10):1220-5.

PMID:
8856002
4.
5.

Fluoxetine versus placebo in posttraumatic stress disorder.

Martenyi F, Brown EB, Zhang H, Prakash A, Koke SC.

J Clin Psychiatry. 2002 Mar;63(3):199-206.

PMID:
11926718
6.

Randomized, double-blind, placebo-controlled trial of fluoxetine treatment for elderly patients with dysthymic disorder.

Devanand DP, Nobler MS, Cheng J, Turret N, Pelton GH, Roose SP, Sackeim HA.

Am J Geriatr Psychiatry. 2005 Jan;13(1):59-68.

PMID:
15653941
7.

Characteristics of fluoxetine versus placebo responders in a randomized trial of geriatric depression.

Ackerman DL, Greenland S, Bystritsky A, Small GW.

Psychopharmacol Bull. 1997;33(4):707-14.

PMID:
9493483
8.

A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.

Goodyer IM, Dubicka B, Wilkinson P, Kelvin R, Roberts C, Byford S, Breen S, Ford C, Barrett B, Leech A, Rothwell J, White L, Harrington R.

Health Technol Assess. 2008 May;12(14):iii-iv, ix-60.

9.

Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.

Lenox-Smith AJ, Jiang Q.

Int Clin Psychopharmacol. 2008 May;23(3):113-9. doi: 10.1097/YIC.0b013e3282f424c2.

PMID:
18408525
10.

A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients.

Nemeroff CB, Thase ME; EPIC 014 Study Group.

J Psychiatr Res. 2007 Apr-Jun;41(3-4):351-9. Epub 2005 Sep 12.

PMID:
16165158
11.
13.

Hypericum perforatum versus fluoxetine in the treatment of mild to moderate depression.

Behnke K, Jensen GS, Graubaum HJ, Gruenwald J.

Adv Ther. 2002 Jan-Feb;19(1):43-52.

PMID:
12008860
14.

Predictors of an acute antidepressant response to fluoxetine and sertraline.

Flament MF, Lane RM, Zhu R, Ying Z.

Int Clin Psychopharmacol. 1999 Sep;14(5):259-75.

PMID:
10529069
15.

Double-blind comparison of fluoxetine and nortriptyline in the treatment of moderate to severe major depression.

Akhondzadeh S, Faraji H, Sadeghi M, Afkham K, Fakhrzadeh H, Kamalipour A.

J Clin Pharm Ther. 2003 Oct;28(5):379-84.

PMID:
14632962
16.
17.

Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression.

Fava M, Rosenbaum JF, Hoog SL, Tepner RG, Kopp JB, Nilsson ME.

J Affect Disord. 2000 Aug;59(2):119-26.

PMID:
10837880
18.

Sertraline versus fluoxetine in the treatment of major depression: a combined analysis of five double-blind comparator studies.

Feiger AD, Flament MF, Boyer P, Gillespie JA.

Int Clin Psychopharmacol. 2003 Jul;18(4):203-10.

PMID:
12817154
20.
Items per page

Supplemental Content

Write to the Help Desk